UBS Group AG Sells 70,240 Shares of Trupanion, Inc. $TRUP

UBS Group AG lowered its position in shares of Trupanion, Inc. (NASDAQ:TRUP) by 39.8% in the fourth quarter, HoldingsChannel reports. The fund owned 106,049 shares of the financial services provider’s stock after selling 70,240 shares during the period. UBS Group AG’s holdings in Trupanion were worth $3,963,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. State Street Corp raised its position in shares of Trupanion by 2.6% during the second quarter. State Street Corp now owns 1,285,419 shares of the financial services provider’s stock worth $71,148,000 after acquiring an additional 32,839 shares during the last quarter. Marshall Wace LLP raised its position in shares of Trupanion by 15.5% during the third quarter. Marshall Wace LLP now owns 1,212,151 shares of the financial services provider’s stock worth $52,462,000 after acquiring an additional 163,101 shares during the last quarter. Millennium Management LLC raised its position in shares of Trupanion by 185.8% during the third quarter. Millennium Management LLC now owns 619,003 shares of the financial services provider’s stock worth $26,790,000 after acquiring an additional 402,421 shares during the last quarter. Dimensional Fund Advisors LP raised its position in shares of Trupanion by 13.5% during the third quarter. Dimensional Fund Advisors LP now owns 540,953 shares of the financial services provider’s stock worth $23,414,000 after acquiring an additional 64,289 shares during the last quarter. Finally, Balyasny Asset Management L.P. raised its position in shares of Trupanion by 8.1% during the second quarter. Balyasny Asset Management L.P. now owns 449,106 shares of the financial services provider’s stock worth $24,858,000 after acquiring an additional 33,650 shares during the last quarter.

Trupanion Stock Up 0.6%

Shares of Trupanion stock opened at $21.98 on Friday. Trupanion, Inc. has a 1 year low of $21.16 and a 1 year high of $57.88. The business has a 50-day moving average of $25.27 and a two-hundred day moving average of $30.99. The company has a market capitalization of $958.77 million, a P/E ratio of 37.25 and a beta of 1.49. The company has a debt-to-equity ratio of 0.25, a current ratio of 1.73 and a quick ratio of 1.73.

Trupanion (NASDAQ:TRUP) last announced its quarterly earnings results on Thursday, April 30th. The financial services provider reported $0.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.07 by $0.04. Trupanion had a return on equity of 6.87% and a net margin of 1.74%.The company had revenue of $384.05 million during the quarter, compared to the consensus estimate of $379.77 million. During the same period in the prior year, the company earned ($0.03) earnings per share. The company’s revenue for the quarter was up 12.3% compared to the same quarter last year. As a group, equities analysts predict that Trupanion, Inc. will post 0.53 EPS for the current year.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on TRUP shares. Stifel Nicolaus dropped their target price on Trupanion from $35.00 to $31.00 and set a “hold” rating for the company in a research report on Tuesday, March 31st. Cantor Fitzgerald dropped their target price on Trupanion from $42.00 to $34.00 and set a “neutral” rating for the company in a research report on Thursday, April 9th. Zacks Research downgraded Trupanion from a “strong-buy” rating to a “hold” rating in a research report on Friday, February 13th. Weiss Ratings downgraded Trupanion from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, March 4th. Finally, Piper Sandler dropped their target price on Trupanion from $60.00 to $45.00 and set an “overweight” rating for the company in a research report on Friday, February 13th. Two equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $42.25.

Insiders Place Their Bets

In other Trupanion news, CRO Emily Dreyer sold 7,792 shares of the stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $28.15, for a total value of $219,344.80. Following the completion of the sale, the executive directly owned 35,627 shares in the company, valued at $1,002,900.05. This represents a 17.95% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Fawwad Qureshi sold 2,837 shares of the stock in a transaction dated Friday, February 27th. The stock was sold at an average price of $26.46, for a total value of $75,067.02. The disclosure for this sale is available in the SEC filing. Insiders sold 21,503 shares of company stock worth $578,537 over the last ninety days. 5.42% of the stock is currently owned by corporate insiders.

Trupanion Company Profile

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.